This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Biostatistics and Epidemiology
趣赢平台 optimizes clients’ clinical trials and disease surveillance studies, swiftly generating crucial insights to protect and enhance the nation's health. Our researchers tackle emerging questions and concerns about vaccine effectiveness and diseases with precision and expertise.
Overview
趣赢平台 is at the forefront of health research, and our biostatisticians and epidemiologists bring innovative approaches to address a wide range of clinical trial, observational, and surveillance studies. Our clients rely on us for expert methodology, innovative infrastructure, experienced coordination, and actionable results.
Our Expertise
Biostatistical Methods
Motivated by a commitment to enhancing health, 趣赢平台 biostatisticians skillfully employ suitable methods to tackle a diverse range of scientific inquiries in both observational and clinical research. Our analyses span from small patient samples in clinical settings to millions of records in electronic health systems, each potentially containing hundreds of data points. When existing methods fall short or the impact of an analytic decision is uncertain, we collaborate with our clients to develop and test new methodologies.
Epidemiologic Studies
趣赢平台’s epidemiologists have been pivotal in critical epidemiological research, employing diverse study methods and designs to analyze data both retrospectively and prospectively. We’ve developed and utilized innovative tools and methods to support epidemiologic studies across a wide range of communicable and non-communicable diseases. Our research has had direct public health and policy impacts, including collaborations on reports about Long COVID, insights into household transmission of SARS-CoV-2, and information on COVID-19 vaccine effectiveness.
Disease Surveillance
趣赢平台 leverages its expertise in epidemiology, statistics, and public health to enhance disease surveillance. By monitoring trends, identifying sentinel events, and tracking key metrics, we equip decision-makers with vital situational awareness. Collaborating with federal and state agencies across areas like infectious disease and substance abuse, we employ rigorous methodologies in both traditional and innovative data collection and analysis, delivering timely insights to drive public health action.
Experts
Meet the Team
-
Sarah Ball
Vice President & Lead Scientific/Epidemiology Advisor
-
Karen Della Torre
Associate Vice President
-
Jeanne Rosenthal
Vice President
-
Kerry Grace Morrissey
Vice President
-
Lori Merrill
Principal Research Associate
-
Marsha Dunn
Vice President
-
Rebecca Fink
Principal Research Scientist
Projects
Keep Reading
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
How does our support for clinical trials reduce new HIV infections and improve care for young people? -
National Cancer Institute (NCI)
Does cancer screening save lives? -
Children’s Hospital of Philadelphia
How do you meet data management and biostatistical expertise needs for a hospital?
Insights
Deep Dive with Our Experts
-
Perspective
The 趣赢平台 Team Behind VISION’s SuccessApril 2024
The VISION Vaccine Effectiveness Network, launched by the Centers for Disease Control and Prevention (CDC) in 2020, spurred a monumental shift in vaccine assessment, guiding…
-
Perspective
VISION Vaccine Effectiveness Network: Why It SucceededSeptember 2023
With the emergency phase of the COVID-19 pandemic behind us, interest has grown in understanding why the VISION Vaccine Effectiveness (VE) Network, launched in 2020…
-
Perspective
Solving the Challenges to Clinical Trial Research in an Uncertain EconomyJanuary 2023
The global pandemic, in its early stages, brought a hailstorm of challenges to businesses, including the business of conducting clinical trials. While our 趣赢平台 colleagues…